EpCYS gene of scrophularia sinensis scpl family acyltransferase and application thereof
By cloning and expressing the EpCYS gene of the SCPL family acyltransferase of Echinacea purpurea, yeast and plant expression vectors were constructed, achieving efficient conversion of chlorogenic acid to cynarine. This solves the problem of low catalytic efficiency in existing technologies and promotes the application of cynarine in pharmaceutical components.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SICHUAN UNIV
- Filing Date
- 2024-12-06
- Publication Date
- 2026-06-09
AI Technical Summary
Existing technologies are insufficient for efficiently catalyzing the formation of cynarine from chlorogenic acid, which limits the biosynthesis and application of cynarine and its derivatives in pharmaceutical formulations.
The gene of EpCYS, an acyltransferase of the SCPL family from Echinacea purpurea, was cloned and expressed. Yeast and plant expression vectors were constructed to achieve heterologous expression of EpCYS in yeast and Nicotiana benthamiana, which catalyzes the production of cynarine from chlorogenic acid.
The successful in vitro and in vivo validation of EpCYS-catalyzed production of cynarine from chlorogenic acid provides a new resource for the biosynthesis of cynarine, promotes its production as a drug component, and demonstrates its biological activities such as hepatoprotection, blood sugar regulation, antibacterial and anti-inflammatory effects, and inhibition of cancer cells.
Smart Images

Figure CN119331891B_ABST